Perspective Therapeutics, Inc. (CATX)

NYSEAMERICAN: CATX · Real-Time Price · USD

3.810

-0.170 (-4.27%)

At close: Aug 13, 2025, 4:00 PM

3.860

+0.050 (1.31%)

After-hours: Aug 13, 2025, 8:00 PM EDT

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $282.81 million as of August 13, 2025. Its market cap has decreased by -64.06% in one year.

Market Cap

282.81M

Enterprise Value

94.80M

1-Year Change

-64.06%

Ranking

#3494

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $282.81M, an increase of 467.89%. That is a compound annual growth rate of 9.18%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	282.80M	31.17%
Dec 31, 2024	215.60M	91.13%
Dec 29, 2023	112.80M	221.37%
Dec 30, 2022	35.10M	-36.18%
Dec 31, 2021	55.00M	39.95%
Dec 31, 2020	39.30M	-6.65%
Dec 31, 2019	42.10M	108.42%
Dec 31, 2018	20.20M	-8.18%
Dec 29, 2017	22.00M	-31.03%
Dec 30, 2016	31.90M	-38.18%
Dec 31, 2015	51.60M	-35.58%
Dec 31, 2014	80.10M	317.19%
Dec 31, 2013	19.20M	-28.89%
Dec 31, 2012	27.00M	41.36%
Dec 30, 2011	19.10M	-28.20%
Dec 31, 2010	26.60M	30.39%
Dec 31, 2009	20.40M	343.48%
Dec 31, 2008	4.60M	-90.09%
Dec 31, 2007	46.40M	-40.28%
Dec 29, 2006	77.70M	9.75%
Dec 30, 2005	70.80M	42.17%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	592.95B
Johnson & Johnson	420.06B
AbbVie	355.91B
UnitedHealth Group	246.17B
AstraZeneca	240.81B
Novartis AG	234.72B
Novo Nordisk	227.37B
Abbott Laboratories	225.22B

Market Cap Rankings